Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure

Artificial Organs

Volumn 29, Issue 4, 2005, Pages 324-328

  Yonekawa, Chikara ^a   Nakae, Hajime ^a   Tajimi, Kimitaka ^a   Asanuma, Yoshihiro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Citrate toxicity; Continuous hemodiafiltration; Interleukin 18; Interleukin 6; Plasma exchange; Postoperative liver failure

Indexed keywords

AFTER-TREATMENT; CITRATE TOXICITY; CONTINUOUS HEMODIAFILTRATION; HEMODIAFILTRATION; INTERLEUKIN-18; INTERLEUKIN6 (IL6); LIVER FAILURE; PLASMA EXCHANGES; POSTOPERATIVE LIVER; POSTOPERATIVE LIVER FAILURE;

PATIENT TREATMENT;

BILIRUBIN; CITRIC ACID; INTERLEUKIN 18; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; HEMODIALYSIS; HUMAN; LIVER FAILURE; LIVER RESECTION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEMODIAFILTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL;

AGED; BILIRUBIN; CITRIC ACID; COMBINED MODALITY THERAPY; FEMALE; HEMODIAFILTRATION; HEPATECTOMY; HUMANS; INTERLEUKIN-18; INTERLEUKIN-6; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PLASMA EXCHANGE; TREATMENT OUTCOME;

EID: 22844433906     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.29054.x     Document Type: Article

References (10)

1. Hirasawa H, Sugai T, Oda S, et al. Efficacy and limitation of apheresis therapy in critical care. Ther Ahper 1997;1:228-32.
2. Sadahiro T, Hirasawa H, Oda S, et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med 2001;29:1386-92.
3. Iwai H, Nagaki M, Naito T, et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998;26:873-6.
4. Nakae H, Yonekawa C, Moon S, Tajimi K. The series-parallel circuit in the treatment of fulminant hepatitis. Ther Apher Dial 2003;8:153-9.
5. Sutton DM, Nair RC, Rock G. Complication of plasma exchange. Transfusion 1989;29:124-7.
6. Ludbrok J, Wynn V. Citrate intoxication. Brit Med J 1958;2:523-8.
7. Nakae H, Zheng YJ, Wada H, Tajimi K, Endo S. Involvement of IL-18 and soluble fats in patients with postoperative hepatic failure. Eur Surg Res 2003;35:61-6.
8. Morita T, Togo S, Kubota T, et al. Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg 2002;9:352-9.
9. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002;26:103-10.
10. Kerkhove MP, Jong KP, Rijken AM, Pont AC, Gulik TM. MARS treatment in posthepatectomy liver failure. Liver Int 2003;23:s44-s51.